About this information
Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA). For additional information, please see the “About Access to Information Requests” webpage.
If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.
*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.
Download datasets of the summaries of completed access to information requests.
Current Search
Report Type
Organization
Disposition
Year
Month
Found 26 record(s)
Req # NFB_AI_2023-2024_5
Audit of spending that was undertaken by the National Film Board between October 2021 and February 2022.Organization: National Film Board
March 2024
Nothing to report this month
Organization: Patented Medicine Prices Review Board Canada
Req # AI_2022-2023_6
Information regarding the contract of Stanex Inc. with the National Film Board.Organization: National Film Board
March 2023
March 2023
Req # A-2023-09059
Copies of all submissions or comments received in response to the PMPRB's 2022 Guidelines consultation, including any late consultation submissions received on December 6th or 7th, 2022. This request runs from October 6th to December 7th, 2022. If Health Canada or any other federal government department provided comments outside of the consultation process I would like a copy of those comments as well. This part of the request also runs from October 6th to December 7th, 2022.Organization: Patented Medicine Prices Review Board Canada
March 2023
Req # A-2023-03268
Part 1: Based on documents disclosed in A-2022-09063, (see PDF pages 67-68), the PMPRB sent a letter to the Minister of Health on or around November 30, 2022. I would like to request a copy of that letter, as well as any response from Health Canada. Part 2: Based on documents disclosed in A-2022-09063, a meeting of the PMPRB occurred on December 5th, 2022 (see PDF page 19 of A-2022-09063). I would like to request the following records related to that meeting: 1. A list of attendees for the meeting. 2. A copy of the calendar invitation for the meeting (regardless of program: Outlook, Google meetup, etc), including any attachments to the invite. 3. The agenda for the meeting. 4. The minutes of the meeting. 5. Any notes taken by participants in the meeting. 6. Any documents distributed or discussed during the meeting (such as handouts or powerpoints). 7. Any emails sent by the participants in the meeting which summarized the meeting or discussed next steps.Organization: Patented Medicine Prices Review Board Canada
March 2023
Req # A-2023-03897
We read the article entitled "After pharma lobbying, minister intervened to suspend drug-price reform" published by the media "The Breach": https://breachmedia.ca/after-pharma-lobbying-minister-intervened-tosuspend-drug-price-reform/ We understand that someone from "The Breach" (its author Kelly Crowe or someone else) has requested information from the PMPRB to write the article. We cannot find this request through the archives of the Access to Information and Personal Information Online Request Service. We therefore request all communication, records and documents which were communicated in this request and/or relating to the information behind the aforementioned article which have been provided to The Breach or its employees.Organization: Patented Medicine Prices Review Board Canada
March 2023
Req # A-2019-00003
•All records concerning or related to the federal government’s Directive on Automated Decision-Making that was prepared by or provided to the PMPRB. (January 1, 2019 to May 2, 2019). •A list of all pending access to information requests at the PMPRB (as of May 2, 2019). •All records relating to the impact of the pending amendments on national pharmacare or the impact of national pharmacare on the pending amendments (From May 2, 2019 to March 1, 2022). •The agenda and minutes for any meetings held by PMPRB executives between January 1, 2018 and May 1, 2019 that concerned the pending amendments. •All revisions or redrafts of the Regulatory Impact Analysis Statement (date of my first request to May 2, 2019). •All records relating to the new basket of countries under the pending amendments, including the inclusion or exclusion of particular countries (date of my first request down to May 2, 2019). •All records relating to the adoption of new pricing factors under the pending amendments (date of my first request down to May 2, 2019). •All records relating to changes in the reporting requirements for patentees under the pending amendments, especially the requirement to report confidential discounts or rebates (date of my first request down to May 2, 2019). •All records relating to a possible decision to distinguish between existing and new medicines in the application of the pending regulations (whether concerning pricing rules, reporting requirements, or any other legal obligation) (date of my first request down to May 2, 2019). •All studies, reports, or other documents prepared by or held by the PMPRB which deal with changes to the content of the pending regulations or the guidelines which are being developed (date of my first request down to May 2, 2019). •All communications regarding the proposed amendments between the PMPRB and one or more of the following organizations: Health Canada, ISED, or CIPO (date of my first request down to May 2, 2019). •All letters or other communications received between September 1, 2018 and May 1, 2019 that question or criticize the pending amendments (date of my first request down to May 2, 2019). •All records generated by the PMPRB or another federal government entity that comment on or analyze the report prepared by Mr. David Dodge (August 23, 2018 to May 2, 2019). •A copy of all training presentations concerning the pending amendments that were held or were supposed to be held between Setptember 1, 2019 and May 1, 2019.Organization: Patented Medicine Prices Review Board Canada
March 2022
Req # A-2022-05127
Copies of all emails to/from Douglas Clark, Melanie Bourassa-Forcier, Tanya Potashnik and Health Canada officials from November 1, 2021 to January 31, 2022.Organization: Patented Medicine Prices Review Board Canada
March 2022
Req # A-2020-05678
Copies of all records of submissions, feedback and other correspondence received by the PMPRB in response to consultations on the Draft Guidelines launched on November 21, 2019.Organization: Patented Medicine Prices Review Board Canada
March 2021